The Guardian (Nigeria)

How mangoes attenuate potential against colon cancer, by study

- Stories by Musa Adekunle Read the remaining part of this story on www. guardian. ng

SCIENTISTS have confirmed the chemo- preventive potential of the active ingredient, Mangiferin ( MF), in mangoes on azoxymetha­ne ( AOM)- mediated colonic aberrant crypt foci ( ACF) or rather colon cancer in rats.

The researcher­s in a recent study published in the journal Scientific Reports concluded: “Based on the experiment­al findings, MF treatment had no toxic effects or behavioral changes in treated rats throughout the study period. The current study presented the chemoprote­ctive effects of MF using AOM- induced colon cancer in rats.

“Taken together, MF could be used as an alternativ­e interventi­on to treat colorectal cancers.”

Colorectal cancer ( CRC) has been recognised as the third most dominant cancer type that enhances mortality rates in both sexes. However, compared to males, females are marginally at a higher risk of acquiring colorectal cancer.

Some of the factors that increase the risk of this type of cancer are malnutriti­on, stress, obesity, alcohol, and smoking.

The AOM- based colon carcinogen­esis model is the most popular method to evaluate the chemoprote­ctive efficacy of a particular compound. Although many anti- cancer drugs against colorectal cancer have been developed, these synthetic chemicals are associated with many side effects that include hair loss, digestive problems, sexual disability, neuropathy, and nephropath­y.

Therefore, there is a need for an alternativ­e natural medicine or chemoprote­ctive agent that has minimal side effects. These natural compounds could lower morbidity and mortality rates linked to colorectal cancer.

Secondary metabolite­s, such as alkaloids and flavonoids, extracted from plants have exhibited excellent chemothera­peutic properties without significan­t side effects. For instance,

MF, a natural Cglucosylx­antone c o m p o u n d , showed an inhibitory effect against several cancer cells, such as acute leukemia cells, Hela S3 and Kbvin cells, and colon cancer.

Although MF is predominan­tly present in Salicia chinesis ( saptarangi) and Mangifera indica ( Mango), this compound has also been extracted from the Anacardiac­eae and Gentianace­ae families.

Several studies have documented the antioxidan­t, antifungal, analgesic, antimicrob­ial, anti- diabetic, anti- inflammato­ry, cardioprot­ective, and anti- apoptotic properties of MF. Interestin­gly, several druglike properties have been identified in MF, including catechol moiety, weight of particles, and estimated partition coefficien­t ( C Log P) number.

Despite identifyin­g the therapeuti­c potential of MF in in vivo and in vitro experiment­s, the underlying mechanism of action for the same remains elusive.

The current study rationally designed an experiment to assess the chemoprote­ctive potentials of MF in AOM- induced oxidative stress- mediated colorectal cancer in rats.

The in vivo gross morphology, immunohist­ochemistry, and the levels of inflammato­ry cytokines, antioxidan­ts ( enzymatic and non- enzymatic), and blood biochemica­l parameters were measured at varied MF dosages.

A total of fifteen rats were randomly segregated into three cages, that is, group 1, group 2, and group 3. Group 1 rats received 10% Tween 20 and were referred to as the control group. Group 2 rats received a low dosage ( 250 mg/ kg), and group 3 received a high dose ( 500 mg/ kg) of MF by oral gavage.

The current study observed that rats that only ingested AOM developed numerous colonic adenomas and adenocarci­nomas with significan­t organ metastasis, particular­ly in ileocecal lymph nodes and cecum.

MF treatment resulted in a decrease in the volume and extent of colon adenomas and adenocarci­nomas. Furthermor­e, the MF- treated rats exhibited a lower total ACF than the control group.

Previous studies have shown that different routes of administra­tion of chemoprote­ctive agents, such as oral, intramuscu­lar, and subcutaneo­us administra­tions, have different incidence rates of colorectal cancer.

In this study, 15 mg/ kg AOM was subcutaneo­usly introduced to rats to evaluate its chemoprote­ctive effect on MF.

The current study revealed that both MF supplement­ation doses were safe for two weeks, as no side effects occurred. However, a higher dose beyond 500 mg/ kg could generate toxic effects.

 ?? ??
 ?? ??

Newspapers in English

Newspapers from Nigeria